Cosmos Pharmaceutical Stock Current Liabilities
COSMOS Pharmaceutical fundamentals help investors to digest information that contributes to COSMOS Pharmaceutical's financial success or failures. It also enables traders to predict the movement of COSMOS Pink Sheet. The fundamental analysis module provides a way to measure COSMOS Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COSMOS Pharmaceutical pink sheet.
COSMOS |
COSMOS Pharmaceutical Company Current Liabilities Analysis
COSMOS Pharmaceutical's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, COSMOS Pharmaceutical has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceutical Retailers (which currently averages 0.0) industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
COSMOS Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses COSMOS Pharmaceutical's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of COSMOS Pharmaceutical could also be used in its relative valuation, which is a method of valuing COSMOS Pharmaceutical by comparing valuation metrics of similar companies.COSMOS Pharmaceutical is currently under evaluation in current liabilities category among its peers.
COSMOS Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0521 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 3.89 B | |||
| Shares Outstanding | 39.6 M | |||
| Shares Owned By Insiders | 51.47 % | |||
| Shares Owned By Institutions | 20.75 % | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 755.41 B | |||
| Gross Profit | 151.45 B | |||
| EBITDA | 48.21 B | |||
| Net Income | 23.16 B | |||
| Total Debt | 3 B | |||
| Book Value Per Share | 5,056 X | |||
| Cash Flow From Operations | 32.19 B | |||
| Earnings Per Share | 4.54 X | |||
| Number Of Employees | 5.1 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 3.89 B | |||
| Total Asset | 363.05 B | |||
| Z Score | 2.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 363.05 B | |||
| Last Dividend Paid | 40.0 |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in COSMOS Pink Sheet
If you are still planning to invest in COSMOS Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the COSMOS Pharmaceutical's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |